394
Views
9
CrossRef citations to date
0
Altmetric
Review Article

Therapeutic management and clinical outcome of autoimmune pancreatitis

, , , , , & show all
Pages 1029-1038 | Received 05 Feb 2011, Accepted 27 Apr 2011, Published online: 30 May 2011

References

  • Rao AS, Palazzo F, Chung J, Hager E, Abdollahi H, Yeo CJ. Diagnostic and treatment modalities for autoimmune pancreatitis. Curr Treat Options Gastroenterol 2006;9:377–84.
  • Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006;6:132–7.
  • Matsushita M, Yamashina M, Ikeura T, Shimatani M, Uchida K, Takaoka M, Okazaki K. Effective steroid pulse therapy for the biliary stenosis caused by autoimmune pancreatitis. Am J Gastroenterol 2007;102:220–1.
  • Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006;41:1197–205.
  • Pezzilli R, Morselli-Labate AM. The concept of autoimmune pancreatitis and its immunological backgrounds. Exp Rev Clin Immunol 2010;6:125–36.
  • Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreatology 2010;10:664–72.
  • Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, International Consensus Diagnostic Criteria for Autoimmune Pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas 2011;40:352–8.
  • Toomey DP, Swan N, Torreggiani W, Conlon KC. Autoimmune pancreatitis: medical and surgical management. JOP 2007;8:335–43.
  • Klöppel G, Lüttges J, Löhr M, Zamboni G, Longnecker D. Autoimmune pancreatitis: pathological, clinical, and immunological features. Pancreas. 2003;27:14–19.
  • Zamboni G, Lüttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552–63.
  • Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 2003;27:110–320.
  • Pezzilli R, Casadei R, Calculli L, Santini D. Autoimmune pancreatitis. A case mimicking carcinoma JOP 2004;5:527–30.
  • Watanabe M, Yamaguchi K, Kobayashi K, Konomi H, Nakamura M, Mizumoto K, Autoimmune pancreatitis diagnosed after pancreatoduodenectomy and successfully treated with low-dose steroid. J Hepatobiliary Pancreat Surg 2007;14:397–400.
  • Padilla D, Cubo T, Villarejo P, Pardo R, Jara A, de la Plaza R, Hernández J. Response to steroid therapy of sclerosing cholangitis after duodenopancreatectomy due to autoimmune pancreatitis. Gut 2005;54:1348–9.
  • Schnelldorfer T, Lewin DN, Adams DB. Long-term results after surgery for autoimmune sclerosing pancreatitis. J Gastrointest Surg 2007;11:56–8.
  • Weber SM, Cubukcu-Dimopulo O, Palesty JA, Suriawinata A, Klimstra D, Brennan MF, Conlon K. Lymphoplasmacytic sclerosing pancreatitis: Inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 2003;7:129–39.
  • Okazaki K. Ursodeoxycholic acid as an alternative therapy for autoimmune pancreatitis. Intern Med 2002;41:1082–3.
  • Pezzilli R, Casadei R, Santini D. Autoimmune pancreatitis associated with anisakis infection. Dig Liver Dis 2007;39:273.
  • Ozden I, Dizdaroğlu F, Poyanli A, Emre A. Spontaneous regression of a pancreatic head mass and biliary obstruction due to autoimmune pancreatitis. Pancreatology 2005;5:300–3.
  • Araki J, Tsujimoto F, Ohta T, Nakajima Y. Natural course of autoimmune pancreatitis without steroid therapy showing hypoechoic masses in the uncinate process and tail of the pancreas on ultrasonography. J Ultrasound Med 2006;25:1063–7.
  • Hirano K, Tada M, Isayama H, Yagioka H, Sasaki T, Kogure H, Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007;56:1719–24.
  • Kamisawa T, Anjiki H, Takuma K, Egawa N, Kubota N. The natural course of autoimmune pancreatitis. Hepatogastroenterology 2009;56:866–70.
  • Chari ST. Current concepts in the treatment of autoimmune pancreatitis. JOP 2007;8:1–3.
  • Fantini L, Zanini N, Fiscaletti M, Calculli L, Casadei R, Campana D, Pezzilli R. Autoimmune pancreatitis: the classification puzzle. Adv Med Sci 2007;52:71–5.
  • Matsubayashi H, Imai K, Kusumoto K, Ono H. Suspected autoimmune pancreatitis-An indication for steroid treatment? Dig Liver Dis 2010;42:525–6.
  • Zamboni G, Capelli P, Scarpa A, Bogina G, Pesci A, Brunello E, Klöppel G. Nonneoplastic mimickers of pancreatic neoplasms. Arch Pathol Lab Med 2009;133:439–53.
  • Otsuki M. Autoimmune pancreatitis: a message from Japan. J Gastroenterol 2007;42 (Suppl XVIII):1–5.
  • Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1–4.
  • Pezzilli R. Acute recurrent pancreatitis: an autoimmune disease? World J Gastroenterol 2008;14:999–1006.
  • Tsubakio K, Kiriyama K, Matsushima N, Taniguchi M, Shizusawa T, Katoh T, Autoimmune pancreatitis successfully treated with ursodeoxycholic acid. Intern Med 2002;41:1142–6.
  • Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732–8.
  • Nishino T, Toki F, Oyama H, Oi I, Kobayashi M, Takasaki K, Shiratori K. Biliary tract involvement in autoimmune pancreatitis. Pancreas 2005;30:76–82.
  • Kamisawa T, Yoshiike M, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005;5:234–8.
  • Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 2004;99:932–7.
  • Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Murase T, Hashimoto M, Takeuchi K. Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis. Lancet 2000;356:910–11.
  • Nobili E, Pezzilli R, Santini D, Campidelli C, Calculli L, Casadei R, Autoimmune pancreatitis associated with high levels of chromogranin A, serotonin and 5-hydroxy indoleacetic acid. Case Rep Gastroenterol 2008;2:11–17.
  • Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc 2002;55:494–9.
  • Sah RP, Pannala R, Chari ST, Sugumar A, Clain JE, Levy MJ, Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol 2010;8:91–6.
  • Ghazale A, Chari ST. Optimising corticosteroid treatment for autoimmune pancreatitis. Gut 2007;56:1650–2.
  • Rueda JC, Duarte-Rey C, Casas N. Successful treatment of relapsing autoimmune pancreatitis in primary Sjögren's syndrome with Rituximab: report of a case and review of the literature. Rheumatol Int 2009;29:1481–5.
  • Miyatani H, Yoshida Y, Ikeda M, Sagihara N. Improvement of thrombocytopenia in a patient with autoimmune pancreatitis after Helicobacter pylori eradication. Intern Med 2008;47:321–2.
  • Manfredi R, Graziani R, Cicero C, Frulloni L, Carbognin G, Mantovani W, Mucelli RP. Autoimmune pancreatitis: CT patterns and their changes after steroid treatment. Radiology 2008;247:435–43.
  • Sahani DV, Sainani NI, Deshpande V, Shaikh MS, Frinkelberg DL, Fernandez-del Castillo C. Autoimmune pancreatitis: disease evolution, staging, response assessment, and CT features that predict response to corticosteroid therapy. Radiology 2009;250:118–29.
  • Morselli-Labate AM, Pezzilli R. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis. J Gastroenterol Hepatol 2009;24:15–36.
  • Nishimori I, Tamakoshi A, Kawa S, Tanaka S, Takeuchi K, Kamisawa T, Research Committee on Intractable Pancreatic Diseases, the Ministry of Health and Welfare of Japan. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan. Pancreas 2006;32:244–8.
  • Tanaka S, Kobayashi T, Nakanishi K, Okubo M, Odawara M, Murase T, Corticosteroid-responsive diabetes mellitus associated with autoimmune pancreatitis: pathological examinations of the endocrine and exocrine pancreas. Ann NY Acad Sci 2002;958:152–9.
  • Kahaleh M, Behm B, Clarke BW, Brock A, Shami VM, De La Rue SA, Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm? (with video). Gastrointest Endosc 2008;67:446–54.
  • Mahajan A, Ho H, Sauer B, Phillips MS, Shami VM, Ellen K, Temporary placement of fully covered self-expandable metal stents in benign biliary strictures: midterm evaluation (with video). Gastrointest Endosc 2009;70:303–9.
  • Pezzilli R, Broccoli PL, Melandri R, Vandelli A, Re G, Fontana G. Exocrine pancreatic involvement in Wegener's granulomatosis. A case report. Ital J Gastroenterol 1991;23:258–60.
  • Toomey DP, Swan N, Torreggiani W, Conlon KC. Autoimmune pancreatitis. Br J Surg 2007;94:1067–74.
  • Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 2006;45:497–501.
  • Kamisawa T, Okamoto A, Wakabayashi T, Watanabe H, Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterol 2008;43:609–13.
  • Frulloni L, Scattolini C, Falconi M, Zamboni G, Capelli P, Manfredi R, Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009;104:2288–94.
  • Borum M, Steinberg W, Steer M, Freedman S, White P. Chronic pancreatitis: a complication of systemic lupus erythematosus. Gastroenterology 1993;104:613–15.
  • Wakabayashi T, Kawaura Y, Satomura Y, Fujii T, Motoo Y, Okai T, Sawabu N. Clinical study of chronic pancreatitis with focal irregular narrowing of the main pancreatic duct and mass formation: comparison with chronic pancreatitis showing diffuse irregular narrowing of the main pancreatic duct. Pancreas 2002;25:283–9.
  • Hardacre JM, Iacobuzio-Donahue CA, Sohn TA, Abraham SC, Yeo CJ, Lillemoe KD, Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis. Ann Surg 2003;237:853–8.
  • Fernandez-del Castillo CF, Sahani DV, Brugge WR, Harris NL, Warshaw AL, Lauwers GY, Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 27-2003. A 36-year-old man with recurrent epigastric pain and elevated amylase levels. N Engl J Med 2003;349:893–901.
  • Tanvetyanon T, Stiff PJ. Recurrent steroid-responsive pancreatitis associated with myelodysplastic syndrome and transformations. Leuk Lymphoma 2005;46:151–4.
  • Wayne M, Delman KA, Kurt T, Grossi R, Sabatini M, Cooperman A. Autoimmune pancreatitis: unveiling a hidden entity. Arch Surg 2005;140:1104–7.
  • Abisi S, Morris-Stiff G, Hill SM, Roberts A, Williams G, Puntis MC. Autoimmune pancreatitis: an underdiagnosed condition in Caucasians. J Hepatobiliary Pancreat Surg 2005;12:332–5.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.